Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Adamis, Antengene, Arca, Atyr, Eli Lilly, Enzychem Lifesciences, Equillium, Henlius, Hoth, Innovent, Kyorin, Mesoblast, Pliant, Redhill, Seattle Genetics, TLC, Verona.